BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19558919)

  • 1. [Multiple primary melanoma].
    Ferreres JR; Moreno A; Marcoval J
    Actas Dermosifiliogr; 2009 Jun; 100(5):414-9. PubMed ID: 19558919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases.
    Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Calzavara Pinton PG
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1333-6. PubMed ID: 17958838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple primary melanoma: epidemiological and prognostic implications; analysis of 36 cases.
    Buljan M; Situm M; Bolanca Z; Zivković MV; Mihić LL
    Coll Antropol; 2010 Apr; 34 Suppl 2():131-4. PubMed ID: 21302712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple primary melanoma: two-year results from a population-based study.
    Titus-Ernstoff L; Perry AE; Spencer SK; Gibson J; Ding J; Cole B; Ernstoff MS
    Arch Dermatol; 2006 Apr; 142(4):433-8. PubMed ID: 16618861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple primary malignant tumors in patients with malignant melanoma of the skin].
    Landthaler M; Braun-Falco O; Bernreiter F; Hölzel D
    Hautarzt; 1992 Jan; 43(1):11-5. PubMed ID: 1612903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
    Uliasz A; Lebwohl M
    Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
    Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
    Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanomas that failed dermoscopic detection: a combined clinicodermoscopic approach for not missing melanoma.
    Puig S; Argenziano G; Zalaudek I; Ferrara G; Palou J; Massi D; Hofmann-Wellenhof R; Soyer HP; Malvehy J
    Dermatol Surg; 2007 Oct; 33(10):1262-73. PubMed ID: 17903162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
    Berwick M; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Busam K; From L; Mujumdar U; Wilcox H; Begg CB;
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1520-5. PubMed ID: 16896043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in incidence of malignant melanoma in the last 19 years in a tertiary hospital on the Mediterranean coast].
    Marcoval J; Moreno A; Torras A; Baumann E; Graells J; Gallego MI
    Actas Dermosifiliogr; 2008; 99(6):464-8. PubMed ID: 18558054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Royal Flying Doctor Service primary care skin cancer clinic: a pilot program for remote Australia.
    Scrace M; Margolis SA
    Rural Remote Health; 2009; 9(1):1048. PubMed ID: 19239334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important risk factors in melanoma from the Dermato-Oncologic Unit of Brescia, Italy.
    Manganoni AM; Zanotti F; Farisoglio C; Feroldi P; Facchetti F; Calzavara-Pinton P
    Dermatol Online J; 2010 Jan; 16(1):17. PubMed ID: 20137759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and epidemiologic profile of melanoma patients according to sun exposure of the tumor site].
    Nagore E; Botella-Estrada R; Requena C; Serra-Guillén C; Martorell A; Hueso L; Llombart B; Sanmartín O; Guillén C
    Actas Dermosifiliogr; 2009 Apr; 100(3):205-11. PubMed ID: 19457306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermotropic malignant melanoma: the distinction between metastatic and new primary lesions in the skin.
    Jackson R
    Can J Surg; 1984 Nov; 27(6):533-5. PubMed ID: 6388769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prevalence of bilateral malignant uveal melanoma].
    Sturm V; Richard G
    Klin Monbl Augenheilkd; 2007 Oct; 224(10):770-4. PubMed ID: 17952820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
    Francken AB; Thompson JF; Bastiaannet E; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):557-62. PubMed ID: 18402322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems in assessing multiple cutaneous melanoma. A review on the accuracy of a population based cancer registry.
    Måsbäck A; Andersson G; Olsson H
    Cancer Epidemiol; 2010 Jun; 34(3):262-6. PubMed ID: 20346747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple primary melanoma and familial melanoma. Risk evaluation and screening tests. How to evaluate the risk of developing a second melanoma? In what family? Should screening methods be implemented? Which ones and why?].
    Grange F
    Ann Dermatol Venereol; 1995; 122(5):365-71. PubMed ID: 8572480
    [No Abstract]   [Full Text] [Related]  

  • 19. Melanoma in situ in Puerto Rico: clinical characteristics and detection patterns.
    Muñoz C; Vázquez-Botet M
    P R Health Sci J; 2004 Sep; 23(3):179-82. PubMed ID: 15631171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple primary melanoblastoma of the skin].
    Vagner RI; Anisimov VV; Kolosov AE
    Vopr Onkol; 1980; 26(11):79-83. PubMed ID: 7456429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.